Rhythm Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, MA

Insiders trading volume in the past year

Rhythm Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Meeker President and CEO, Director $15.2M -$820K -5.13% Feb 14, 2025
Hunter C. Smith Chief Financial Officer $7.42M -$343K -4.42% Feb 14, 2025
Yann Mazabraud EVP, Head of International $2.34M -$4.94M -67.9% Apr 8, 2025
Pamela J. Cramer Chief Human Resources Officer $1.77M -$4.63M -72.4% Apr 8, 2025
Alastair Garfield Chief Scientific Officer $1.52M Feb 14, 2025
Jennifer Kayden Lee EVP, Head of North America $1.28M -$5.3M -80.6% Feb 14, 2025
Joseph Shulman Chief Technical Officer $1.19M -$2.07M -63.5% Feb 14, 2025
Linda Shapiro Manning Chief Medical Officer $563K Feb 9, 2022
Edward T. Mathers Director $343K Jun 21, 2024
William T. Roberts Chief Accounting Officer $279K Mar 29, 2023
Christopher Paul German Corporate Controller & CAO $277K -$55K -16.6% Mar 20, 2025
Jennifer L. Good Director $157K -$4.27M -96.4% Sep 17, 2024
Lynn A. Tetrault Director $152K -$1.69M -91.8% Sep 9, 2024
Christophe Jean Director $117K Jun 21, 2024
D. W. J. Mcgirr Director $117K Jun 21, 2024
Stuart A. Arbuckle Director $117K Jun 21, 2024
Camille L. Bedrosian Director $117K Jun 21, 2024

Recent Insider Transactions by Companies or Individuals for Rhythm Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.